ADVM — Adverum Biotechnologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Adverum Biotechnologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	166	430	305	186	96.5
Net Total Receivables	—	—	5.71	0	—
Prepaid Expenses
Total Current Assets	176	434	317	191	103
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	45.8	47.1	119	114	67
Long Term Notes Receivable
Other Long Term Assets
Total Assets	223	483	440	308	173
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	19.4	20.9	21.3	32.2	24.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	47.8	48.2	124	127	89.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	175	434	316	182	83.5
Total Liabilities & Shareholders' Equity	223	483	440	308	173
Total Common Shares Outstanding